Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Barry Rumack to Excipients

This is a "connection" page, showing publications Barry Rumack has written about Excipients.

 
Connection Strength
 
 
 
0.151
 
  1. Golightly LK, Smolinske SS, Bennett ML, Sutherland EW, Rumack BH. Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II). Med Toxicol Adverse Drug Exp. 1988 May-Jun; 3(3):209-40.
    View in: PubMed
    Score: 0.076
  2. Golightly LK, Smolinske SS, Bennett ML, Sutherland EW, Rumack BH. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I). Med Toxicol Adverse Drug Exp. 1988 Mar-Apr; 3(2):128-65.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)